Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring Glucocorticoid Sensitivity-Reference-Cited by-同舟云学术

Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring Glucocorticoid Sensitivity

Published:2013-02 Issue:2 Volume:19 Page:283-292
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Musch Eugen,Lutfi Tamim,von Stein Petra,Zargari Arezou,Admyre Charlotte,Malek Mouhamad,Löfberg Robert,von Stein Oliver D.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference41 articles.

1. Recent Insights Into the Genetics of Inflammatory Bowel Disease

2. Adherent-invasiveEscherichia colitarget the epithelial barrier

3. Smoking, Physical Activity, Nutrition and Lifestyle: Environmental Factors and Their Impact on IBD

4. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds;Biomedicine & Pharmacotherapy;2024-09

2. The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management;Medicinal Research Reviews;2024-01-16

3. From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems;Journal of Controlled Release;2023-09

4. Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies;Cells;2023-07-27

5. Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors;Biomedicines;2022-11-08